Dipharma is thrilled to announce that Pharma Tech Outlook awarded Dipharma as one of the Top Contract Manufacturing Organizations for 2024.
Read the interview with our colleague, Andrea Confetti, Exclusive Synthesis Business Unit Leader, to learn more about our company, that this year, celebrates 75 years of reliability!
Andrea Confetti explains how Dipharma partners with the top-notch pharmaceutical companies to develop and manufacture their innovative small-molecules.
Dipharma accelerates their journey to success, optimizing costs and accelerating high-quality drug development.
For further information about our CDMO experience, please do not hesitate to contact us: https://www.dipharma.com/contacts/.
We would be delighted to address any inquiries you may have and to showcase our CDMO solutions.
The interview is also available online, at the following link: https://www.pharmatechoutlook.com/dipharma
Furthermore, the article will also be featured in the forthcoming special print edition on Contract Manufacturing Organization 2024.
For more information
Paola Clerici
Communication Manager
DIPHARMA FRANCIS S.r.l.
paola.clerici@dipharma.com
